Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

254 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Time to Conversion to an Everolimus-Based Regimen: Renal Outcomes in Liver Transplant Recipients From the EVEROLIVER Registry.
Saliba F, Dharancy S, Salamé E, Conti F, Eyraud D, Radenne S, Antonini T, Guillaud O, Guguenheim J, Neau-Cransac M, Demartin E, Lasailly G, Duvoux C, Sobesky R, Coilly A, Tresson S, Cailliez V, Boillot O, Pageaux GP, Samuel D, Calmus Y, Dumortier J. Saliba F, et al. Among authors: calmus y. Liver Transpl. 2020 Nov;26(11):1465-1476. doi: 10.1002/lt.25879. Epub 2020 Oct 12. Liver Transpl. 2020. PMID: 32869469
[Renal failure following liver transplantation].
Calmus Y, Pageaux G. Calmus Y, et al. Presse Med. 2009 Sep;38(9):1314-8. doi: 10.1016/j.lpm.2009.05.006. Epub 2009 Jun 27. Presse Med. 2009. PMID: 19560896 Review. French.
Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study.
Karie-Guigues S, Janus N, Saliba F, Dumortier J, Duvoux C, Calmus Y, Lorho R, Deray G, Launay-Vacher V, Pageaux GP. Karie-Guigues S, et al. Among authors: calmus y. Liver Transpl. 2009 Sep;15(9):1083-91. doi: 10.1002/lt.21803. Liver Transpl. 2009. PMID: 19718632 Free article.
Use of everolimus in liver transplantation: The French experience.
Dumortier J, Dharancy S, Calmus Y, Duvoux C, Durand F, Salamé E, Saliba F. Dumortier J, et al. Among authors: calmus y. Transplant Rev (Orlando). 2016 Jul;30(3):161-70. doi: 10.1016/j.trre.2015.12.003. Epub 2016 Mar 18. Transplant Rev (Orlando). 2016. PMID: 27083870 Review.
Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter Study.
Saliba F, Rostaing L, Gugenheim J, Durand F, Radenne S, Leroy V, Neau-Cransac M, Calmus Y, Salamé E, Pageaux GP, Duvoux C, Taguieva N, Sinnasse-Raymond G, Sebagh M, Samuel D, Marquet P. Saliba F, et al. Among authors: calmus y. Transplantation. 2016 Aug;100(8):1705-13. doi: 10.1097/TP.0000000000001228. Transplantation. 2016. PMID: 27454919 Clinical Trial.
Early Switch From Tacrolimus to Everolimus After Liver Transplantation: Outcomes at 2 Years.
Saliba F, Duvoux C, Dharancy S, Dumortier J, Calmus Y, Gugenheim J, Kamar N, Salamé E, Neau-Cransac M, Vanlemmens C, Durand F, Pageaux G, Leroy V, Hardwigsen J, Gharbi H, Masson C, Tindel M, Conti F. Saliba F, et al. Among authors: calmus y. Liver Transpl. 2019 Dec;25(12):1822-1832. doi: 10.1002/lt.25664. Liver Transpl. 2019. PMID: 31631501 Free PMC article.
Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients.
Calmus Y, Scheele JR, Gonzalez-Pinto I, Jaurrieta EJ, Klar E, Pageaux GP, Scudamore CH, Cuervas-Mons V, Metselaar HJ, Prestele H, Girault D. Calmus Y, et al. Liver Transpl. 2002 Feb;8(2):123-31. doi: 10.1053/jlts.2002.30882. Liver Transpl. 2002. PMID: 11862588 Free article. Clinical Trial.
254 results